Early detection of chronic liver disease
On-demand recorded 15 Aug 2023
Nationally, more than 6 million Australians suffer from chronic liver disease. Cirrhosis can be suspected by a thorough clinical assessment, but compensated liver disease is often asymptomatic. Select investigations are therefore critical for identifying patients with advanced liver disease and cirrhosis.
Biomarkers and validated serum tests can evaluate liver damage and synthetic function. Non-invasive imaging techniques, from basic ultrasound to elastography, are critical adjuncts to the clinical assessment of cirrhosis.
Learning outcomes
- Identify and assess patients at high risk of developing chronic liver disease to facilitate early diagnosis and improve patient outcomes
- Develop a management plan with the patient that includes non-pharmacological and pharmacological treatments that address treatment goals and targets
- Understanding the early diagnosis impacting liver cancer
This event is part of Victorian Comprehensive Cancer Centre Alliance- 3 part webinar series. Events in this series are:
Facilitator
Assoc Prof Joel Rhee
Chair RACGP Specific Interests Cancer and Palliative Care
Joel is an academic GP leading the Discipline of General Practice and Primary Care at the School of Population Health, Faculty of Medicine and Health, UNSW Sydney. He is a teacher, researcher, supervisor, and clinician with a passion for improving the delivery of care by primary healthcare professionals to people who are most in need. Especially people with palliative and supportive care needs, and people with advanced and chronic conditions, particularly cancer.
Presenters
Professor Jon Emery
Herman Professor of Primary Care Cancer Research, Director of PC4, Victorian Comprehensive Cancer Centre (VCCC) Primary Care Research and Education Lead, NHMRC Leadership Fellow
Professor Jon Emery is the Herman Professor of Primary Care Cancer Research at the University of Melbourne, a new Chair developed within the Victorian Comprehensive Cancer Centre. He is an NHMRC Practitioner Fellow, Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4), and a Visiting Research Fellow at the University of Cambridge. He studied medicine at Cambridge and Oxford and obtained his DPhil at Oxford on computer decision support to assess cancer risk in general practice. His research interests are in the role of primary care in cancer prevention, diagnosis and follow-up, and primary care trials of complex interventions.
Professor Leon Adams
Consultant Hepatologist
Prof Leon Adams provides gastroenterology and hepatology services at Hollywood Private Hospital. He is a local graduate who underwent gastroenterology training in Perth before undertaking a fellowship at the Mayo Clinic, United States and completing a PhD at The University of Western Australia (UWA). His interests include non-alcoholic fatty liver disease, viral hepatitis, hepatocellular carcinoma, autoimmune liver disease, cirrhosis, gastroscopy and colonoscopy.
Dr Nicole Allard
Post-doctoral Researcher and Medical Epidemiologist, VIDRL
Dr Nicole Allard is a post-doctoral researcher and medical epidemiologist at VIDRL, a senior lecturer at the Department of Infectious Diseases at University of Melbourne and a general practitioner at cohealth. She is Co-Chair of the National COVID-19 Evidence Taskforce Primary & Chronic Care Panel and on the COVID 19 Guidelines Leadership Group and was co-Chair for the Expert Reference Committee of the recently published Liver Cancer Road Map and HCC surveillance guidelines for Cancer Council Australia. She has been involved in education of general practitioners particularly in the area of viral hepatitis for over 10 years.